Princeton, NJ, United States of America

Douglas W Phillipson

This inventor holds 3 USPTO granted patents. Top assignees: E. R. Squibb Sons, Inc., American Cyanamid Company. Active years: 1991-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas W Phillipson. Retrieved from https://idiyas.com/inventor/douglas-w-phillipson-k9sba2h7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • New Haven, CT (US) (1993)
  • Princeton, NJ (US) (1991 - 1994)

Company Filing History:


Years Active: 1991-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Douglas W. Phillipson

Introduction

Douglas W. Phillipson is a notable inventor based in Princeton, NJ, whose contributions to the field of microbiology have led to significant advancements in antibiotic development. With three patents to his name, Phillipson has demonstrated a commitment to exploring novel compounds that hold the potential to revolutionize medical treatments.

Latest Patents

Among Phillipson's latest patents is the formulation of Scopularin, a novel antibiotic substance prepared through the cultivation of the microorganism Scopulariopsis, A.T.C.C. No. 20,914. This innovative compound, along with its alcohol derivative, has shown promising cytochrome P450 inhibition activity, suggesting its potential use in various therapeutic applications. Additionally, he has developed a series of antibiotic substances encapsulated in the patent for 4-methoxy-5-methyl-pyran-3-ol and its derivatives. These novel natural products exemplify his commitment to advancing medical science, as they too possess cytochrome P450 inhibition properties.

Career Highlights

Phillipson's career includes significant tenures at well-respected companies such as E.R. Squibb & Sons, Inc. and American Cyanamid Company. His work in these prestigious institutions has not only enhanced his expertise but has also provided a platform for the development of his pioneering inventions.

Collaborations

Throughout his career, Phillipson has collaborated with talented individuals, including Joseph O'Sullivan and Henner Straub. These partnerships have fostered an environment of creativity and innovation, allowing for the exchange of ideas that have contributed to the successful development of several of his patents.

Conclusion

Douglas W. Phillipson embodies the spirit of innovation, leaving an indelible mark on antibiotic research and development. His patents reflect a dedication to improving healthcare. As he continues to push the boundaries of scientific understanding, Phillipson remains a significant figure in the realm of microbiological inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…